Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Osteoporosis Drug Prompts Increase in Certain Bone Cells

Scientists not sure if finding points to potential problems; maker stands by medication

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Abdominoplasty
Acidophilus
Adhesions
Amebiasis
More...

Related Healthscout Videos
 border=
Custom Ankle Replacements
Recipe for a Healthy Holiday
Custom Ankle Replacements
Replacing Worn Out Wrists
More...

Related Animations
 border=
GERD
Osteoporosis Basics
PPI Therapy
Rheumatoid Arthritis
More...

Related Drug Information
 border=
Aciphex
Klor-Con
Klor-Con ER
Nexium
More...

Related News Articles
 border=
Health Tip: Warning Signs of Binge Eating Disorder
Spice Compounds May Stem Tumor Growth
Menopause Often Means Worsening Cholesterol
Health Tip: Understanding Crohn's Disease
More...

WEDNESDAY, Dec. 31 (HealthDay News) -- Women who took the osteoporosis drug Fosamax for up to three years saw an increase in their number of osteoclasts, or cells that remove old, brittle bone, a new study says.

These women also had "giant" osteoclasts -- single cells fused together -- with as many as 40 nuclei. Normally, one would see only seven or eight nuclei in one grouping, the study authors said.

Text Continues Below



At this point, it's unclear what these findings mean in the "real world."

"Seven or eight cells fused together are more efficient at dissolving calcium from the bone and remodeling," said Dr. James Liu, chairman of the department of obstetrics and gynecology at MacDonald Women's Hospital at Case Medical Center, University Hospitals in Cleveland. "[The study authors] don't know what this means beyond that. Right now, we're just learning these nuances."

Whether these findings will signal future problems is an open question, agreed study lead author Dr. Robert S. Weinstein, a staff physician at Central Arkansas Veterans Healthcare System and a professor of medicine at University of Arkansas for Medical Sciences, both in Little Rock.

"These drugs were used for two to three years in the trial, but clinicians today use them for five and 10 years, and we know these cells accumulate and are there even before the drug is stopped," he said. "It's conceivable there could be a problem at some point. Works need to be done on what is the fate of these drugs."

The findings were published in the Jan. 1 issue of the New England Journal of Medicine.

A second paper in the journal -- a letter to the editor from U.S. Food and Drug Administration epidemiologist Diane K. Wysowski -- noted an increase in the number of reports of esophageal cancer among people taking Fosamax (alendronate).

"Bone is a dynamic tissue -- it continually remodels and repairs itself," Weinstein explained. "Just like an aircraft wing after many flights gets fatigue damage and needs to be repaired, bone also bears the weight of individuals and undergoes damage and needs repair. There's a system [in which] cells remove the old pockets that are no longer at full capacity and replaces them with new bone.

Page:  1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 12/31/2008

Related Links
 border=
From Healthscout's partner site on acid reflux, AcidRefluxConnection.com
SYMPTOMS: Learn about the symptoms of acid reflux disease
DRUGS: Common medications used to treat heartburn
TREATMENT: Lifestyle changes, medication, and surgeryoptions





SOURCES: James Liu, M.D., chairman, department of obstetrics and gynecology, MacDonald Women's Hospital, Case Medical Center, University Hospitals, Cleveland; Robert S. Weinstein, M.D., staff physician, Central Arkansas Veterans Healthcare System, and professor of medicine, University of Arkansas for Medical Sciences, both in Little Rock; Dec. 30, 2008, news release, Merck & Co.; Jan. 1, 2009, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy